Missing/wrong data?
Log in to edit
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
scientific article published on 02 August 2019
Author/s
author: Troels K Bergmann, Morten Mau-Sorensen, Flemming Nielsen, Kim Brosen, Mansoor Raza Mirza
Work details
Publication date
August 2, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.